Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature

Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature

Immunocompromised patients still experience unpredictable courses of COVID-19, despite that effective vaccines and drugs against SARS-CoV-2 are now available. Antiviral combination regimens may have a role in SARS-CoV-2 infection in immunocompromised hosts, but current knowledge is still limited. We...

Full description

Bibliographic Details
Main Authors: Davide Marangoni, Roberta Maria Antonello, Marco Coppi, Marianna Palazzo, Luca Nassi, Noemi Streva, Laura Povolo, Francesca Malentacchi, Lorenzo Zammarchi, Gian Maria Rossolini, Alessandro Maria Vannucchi, Alessandro Bartoloni, Michele Spinicci
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Antiviral
Remdesivir
Relapsing
Association
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223005465

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223005465

Similar Items